Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
10/08/2026 21:36
BRIEF-Interpace Biosciences Q2 Revenue USD 9.131 Million Aug 10 (Reuters) - Interpace Biosciences Q2 operating income USD 321 thousand.
- Q2 net income USD 158 thousand
- Q2 operating expenses USD 5.332 million
- Q2 gross profit USD 5.653 million
- Q2 net income continuing operations USD 266 thousand
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million